| US5731303A (en) | 1985-12-04 | 1998-03-24 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery compositions |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US4863970A (en) | 1986-11-14 | 1989-09-05 | Theratech, Inc. | Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols |
| US5332577A (en) | 1988-12-27 | 1994-07-26 | Dermamed | Transdermal administration to humans and animals |
| US5152997A (en) | 1990-12-11 | 1992-10-06 | Theratech, Inc. | Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels |
| JPH08501529A (en) | 1992-06-11 | 1996-02-20 | セラテック・インコーポレイテッド | Use of glycerin to alleviate skin-penetrating drug administration |
| US5723114A (en) | 1993-03-19 | 1998-03-03 | Cellegy Pharmaceuticals Inc. | Penetration enhancing compositions and methods of their use |
| US5760096A (en) | 1996-10-18 | 1998-06-02 | Thornfeldt; Carl R. | Potent penetration enhancers |
| US5908619A (en) | 1997-01-09 | 1999-06-01 | Minnesota Mining And Manufacturing Company | Hydroalcoholic compositions thickened using surfactant/polymer complexes |
| US6019997A (en) | 1997-01-09 | 2000-02-01 | Minnesota Mining And Manufacturing | Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents |
| ATE418988T1 (en) | 1997-11-10 | 2009-01-15 | Strakan Int Ltd | PENETRATION-PROMOTING AND IRRITATION-REDUCING SYSTEMS WITH TESTOSTERONE |
| AU1728099A (en) | 1997-12-22 | 1999-07-12 | Alza Corporation | Monoglyceride and ethyl palmitate permeation enhancer compositions |
| ES2359973T3 (en) | 1998-03-19 | 2011-05-30 | MERCK SHARP & DOHME CORP. | LIQUID POLYMER COMPOSITIONS FOR THE CONTROLLED RELEASE OF BIOACTIVE SUBSTANCES. |
| WO1999047073A1 (en) | 1998-03-19 | 1999-09-23 | Merck & Co., Inc. | Liquid polymeric compositions for controlled release of bioactive substances |
| US8980290B2 (en) | 2000-08-03 | 2015-03-17 | Antares Pharma Ipl Ag | Transdermal compositions for anticholinergic agents |
| US20040198706A1 (en) | 2003-03-11 | 2004-10-07 | Carrara Dario Norberto R. | Methods and formulations for transdermal or transmucosal application of active agents |
| ATE355854T1 (en)* | 2000-08-03 | 2007-03-15 | Antares Pharma Ipl Ag | NEW COMPOSITION FOR TRANSDERMAL AND/OR TRANSMUCOSAL APPLICATION OF ACTIVE INGREDIENTS WITH A SUITABLE THERAPEUTIC MIRROR |
| DE60141587D1 (en) | 2000-08-30 | 2010-04-29 | Besins Int Lab | PROCESS FOR TREATING EFFECTS AND INCREASING LIBIDO IN MEN |
| US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| TWI331522B (en) | 2001-06-22 | 2010-10-11 | Cpex Pharmaceuticals Inc | Pharmaceutical composition |
| JP3909812B2 (en) | 2001-07-19 | 2007-04-25 | 富士フイルム株式会社 | Display element and exposure element |
| US20030175329A1 (en) | 2001-10-04 | 2003-09-18 | Cellegy Pharmaceuticals, Inc. | Semisolid topical hormonal compositions and methods for treatment |
| FR2832311B1 (en) | 2001-11-21 | 2004-04-16 | Besins Int Belgique | FILM-FORMING POWDER, COMPOSITIONS COMPRISING SAME, PREPARATION METHODS AND USES THEREOF |
| FR2834212B1 (en) | 2001-12-27 | 2004-07-09 | Besins Int Belgique | USE OF IMMEDIATE RELEASE POWDER IN PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS |
| MY139721A (en) | 2002-04-19 | 2009-10-30 | Cpex Pharmaceuticals Inc | Pharmaceutical composition |
| EP2266533A3 (en) | 2002-06-25 | 2011-12-14 | Acrux DDS Pty Ltd | Transdermal delivery rate control using amorphous pharmaceutical compositions |
| FR2851470B1 (en) | 2003-02-20 | 2007-11-16 | Besins Int Belgique | PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL OR TRANSMUCTIVE DELIVERY |
| WO2005000241A2 (en) | 2003-06-23 | 2005-01-06 | Macrochem Corporation | Compositons and methods for topical administration |
| EP1648364A4 (en) | 2003-07-11 | 2010-05-26 | Macrochem Corp | Pharmaceutical compositions for topical application |
| CA2624788C (en) | 2005-10-12 | 2011-04-19 | Unimed Pharmaceuticals, Llc | Improved testosterone gel and method of use |
| US20120022033A1 (en)* | 2010-07-23 | 2012-01-26 | Biosante Pharmaceuticals, Inc. | Methods for decreasing cardiovascular risk in postmenopausal women |
| JO3755B1 (en) | 2011-01-26 | 2021-01-31 | Ferring Bv | Testosterone formulations |
| US20130224268A1 (en) | 2012-02-27 | 2013-08-29 | Newgen Biopharma Corp. | Topical delivery of hormonal and non hormonal nano formulations, methods of making and using the same |